These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29369515)

  • 21. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
    Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
    J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric diffuse intrinsic pontine glioma patients from a single center.
    Kebudi R; Cakir FB; Agaoglu FY; Gorgun O; Ayan I; Darendeliler E
    Childs Nerv Syst; 2013 Apr; 29(4):583-8. PubMed ID: 23224361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma.
    Muroi A; Mizumoto M; Ishikawa E; Ihara S; Fukushima H; Tsurubuchi T; Sakurai H; Matsumura A
    Childs Nerv Syst; 2020 Mar; 36(3):507-512. PubMed ID: 31728705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
    Mankuzhy NP; Tringale KR; Dunkel IJ; Farouk Sait S; Souweidane MM; Khakoo Y; Karajannis MA; Wolden S
    Pediatr Blood Cancer; 2024 May; 71(5):e30929. PubMed ID: 38430472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.
    Janssens GO; Jansen MH; Lauwers SJ; Nowak PJ; Oldenburger FR; Bouffet E; Saran F; Kamphuis-van Ulzen K; van Lindert EJ; Schieving JH; Boterberg T; Kaspers GJ; Span PN; Kaanders JH; Gidding CE; Hargrave D
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):315-20. PubMed ID: 22682807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma.
    Fried I; Lossos A; Ben Ami T; Dvir R; Toledano H; Ben Arush MW; Postovski S; Abu Kuidar A; Yalon M; Weintraub M; Benifla M
    J Neurooncol; 2018 Jan; 136(1):189-195. PubMed ID: 29143272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
    Gállego Pérez-Larraya J; Garcia-Moure M; Labiano S; Patiño-García A; Dobbs J; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; Puigdelloses M; Laspidea V; Astigarraga I; Lopez-Ibor B; Cruz O; Oscoz Lizarbe M; Hervas-Stubbs S; Alkorta-Aranburu G; Tamayo I; Tavira B; Hernandez-Alcoceba R; Jones C; Dharmadhikari G; Ruiz-Moreno C; Stunnenberg H; Hulleman E; van der Lugt J; Idoate MÁ; Diez-Valle R; Esparragosa Vázquez I; Villalba M; de Andrea C; Núñez-Córdoba JM; Ewald B; Robbins J; Fueyo J; Gomez-Manzano C; Lang FF; Tejada S; Alonso MM
    N Engl J Med; 2022 Jun; 386(26):2471-2481. PubMed ID: 35767439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Formula: see text] The neuropsychological profile of children with Diffuse Intrinsic Pontine Glioma (DIPG) before and after radiation therapy: A prospective longitudinal study.
    Rhodes A; Martin S; Toledo-Tamula MA; Loucas C; Glod J; Warren KE; Wolters PL
    Child Neuropsychol; 2023 Aug; 29(6):934-958. PubMed ID: 36369715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.
    Bartels U; Wolff J; Gore L; Dunkel I; Gilheeney S; Allen J; Goldman S; Yalon M; Packer RJ; Korones DN; Smith A; Cohen K; Kuttesch J; Strother D; Baruchel S; Gammon J; Kowalski M; Bouffet E
    Neuro Oncol; 2014 Nov; 16(11):1554-9. PubMed ID: 24847085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 Cases.
    Wang ZJ; Ge Y; Altinok D; Poulik J; Sood S; Taub JW; Edwards H; Kieran MW; Steven M
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):e332-e335. PubMed ID: 28234741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.
    Müller K; Scheithauer H; Pietschmann S; Hoffmann M; Rössler J; Graf N; Baumert BG; Christiansen H; Kortmann RD; Kramm CM; von Bueren AO
    Radiat Oncol; 2014 Aug; 9():177. PubMed ID: 25112658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.
    Krishnatry R; Manjali JJ; Chinnaswamy G; Chatterjee A; Goda JS; Janu A; Sahu A; Jalali R; Gupta T
    Jpn J Clin Oncol; 2021 Apr; 51(5):762-768. PubMed ID: 33521824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma.
    Tinkle CL; Simone B; Chiang J; Li X; Campbell K; Han Y; Li Y; Hover LD; Molitoris JK; Becksfort J; Lucas JT; Patay Z; Baker SJ; Broniscer A; Merchant TE
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):838-847. PubMed ID: 31785339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of diffuse pontine gliomas in children: recent developments.
    Kebudi R; Cakir FB
    Paediatr Drugs; 2013 Oct; 15(5):351-62. PubMed ID: 23719782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.
    Macy ME; Kieran MW; Chi SN; Cohen KJ; MacDonald TJ; Smith AA; Etzl MM; Kuei MC; Donson AM; Gore L; DiRenzo J; Trippett TM; Ostrovnaya I; Narendran A; Foreman NK; Dunkel IJ
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
    Gwak HS; Park HJ
    Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.
    Porkholm M; Valanne L; Lönnqvist T; Holm S; Lannering B; Riikonen P; Wojcik D; Sehested A; Clausen N; Harila-Saari A; Schomerus E; Thorarinsdottir HK; Lähteenmäki P; Arola M; Thomassen H; Saarinen-Pihkala UM; Kivivuori SM
    Pediatr Blood Cancer; 2014 Sep; 61(9):1603-9. PubMed ID: 24692119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial.
    Zaghloul MS; Eldebawy E; Ahmed S; Mousa AG; Amin A; Refaat A; Zaky I; Elkhateeb N; Sabry M
    Radiother Oncol; 2014 Apr; 111(1):35-40. PubMed ID: 24560760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
    Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
    J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.